RA CAPITAL MANAGEMENT, L.P. purchased 0.1% of their position (4.80K shares) of HEMAB THERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $119.8K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/21/2026ACC: 0001231919-26-000521
Director10% Owner
Since Apr 2026
+4.80K
Net shares
Net buyer
$119.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
4.80K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+3.80K
Price / share
$24.97
Trade value
$94.94K
% of position
0.1%
5/19/2026
6.37M→6.38M
Common Stock
Indirect
Shares
+996.00
Price / share
$24.94
Trade value
$24.84K
% of position
0.0%
5/20/2026
6.38M→6.38M
Total
Net shares
+4.80K
Net value
$119.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/19/2026 | P · Purchase | +3.80K | $24.97 | $94.94K | 0.1% | 6.37M | 6.38M |
| Common Stock Indirect | 5/20/2026 | P · Purchase | +996.00 | $24.94 | $24.84K | 0.0% | 6.38M | 6.38M |
| Total | +4.80K | $119.78K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.01M
Common Stock
IndirectShares owned354.94K
Total
1.36M indirect1.36M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.01M | Indirect |
| Common Stock | 354.94K | Indirect |
| Total | 1.36M | 1.36M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported